Belite Bio Inc ADR

10-Year Study

BLTE.US · Healthcare · US · Common Stock

Executive Summary: Belite Bio Inc ADR has compounded at 57.2% annually over the last 10 years, with a maximum drawdown of 67.8% and an annualized volatility of 126.3%.

1Y CAGR
+164.0%
3Y CAGR
+116.9%
5Y CAGR
+57.2%
10Y CAGR
+57.2%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
67.8%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
1.31
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
2.46
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
89.3%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · +153.5%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · -1.2%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
75%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
20265.712.6-16.2-0.9————————-1.2%
2025-8.0-1.415.8-7.25.5-11.112.7-3.017.443.129.816.4153.5%
2024-5.16.5-17.05.820.6-6.78.4-1.7-3.742.1-5.0-0.337.9%
2023-0.810.7-9.7-3.2-43.0-13.362.547.9-7.317.812.28.751.8%
2022—41.9-60.9-17.642.8106.07.9-4.44.5-13.412.7-8.030.0%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 126.3%. The dominant macroeconomic risk driver is SHV.US, accounting for 51.9% of variance. Idiosyncratic stock-specific factors contribute 23.4%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2022-01-0110000
2022-02-0114193.270531809605
2022-03-015543.572136450963
2022-04-014568.593555037786
2022-05-016522.864452518538
2022-06-0113433.994646258421
2022-07-0114495.254338930088
2022-08-0113852.458834019199
2022-09-0114473.684019973345
2022-10-0112540.983441449336
2022-11-0114137.187044248185
2022-12-0113004.74529901927
2023-01-0112894.73667233989
2023-02-0114279.551149362676
2023-03-0112899.05073613124
2023-04-0112480.58654837046
2023-05-017113.891191933249
2023-06-016164.797157836636
2023-07-0110017.256123510613
2023-08-0114818.809123281208
2023-09-0113740.293175444147
2023-10-0116182.05328134725
2023-11-0118149.266370202047
2023-12-0119736.8418454182
2024-01-0118735.979045825407
2024-02-0119952.54503498561
2024-03-0116553.062767403197
2024-04-0117515.098992873856
2024-05-0121117.342258649638
2024-06-0119706.64339887876
2024-07-0121354.61576717379
2024-08-0121000.86253628323
2024-09-0120224.331053840553
2024-10-0128735.97891417063
2024-11-0127290.767544068967
2024-12-0127221.742523407396
2025-01-0125038.826244985186
2025-02-0124676.444886511938
2025-03-0128567.730426308048
2025-04-0126522.86418920898
2025-05-0127985.331814476034
2025-06-0124892.14807607935
2025-07-0128045.72870755491
2025-08-0127191.54407686796
2025-09-0131924.072055976976
2025-10-0145688.09258227354
2025-11-0159292.49274829021
2025-12-0169007.76440640645
2026-01-0172907.67807378527
2026-02-0182096.63394935703
2026-03-0168783.43308925634
2026-04-0168183.77822225894
Annual Return Matrix
YearAnnual Return
20230.5176646209985072
20240.37923497267759565
20251.5350237717908084
2026-0.01194048512128032
Total Factor Risk
1.2633012531602779
VTI.US Exposure
0.007824900872020667
VEA.US Exposure
0.0011479475149612692
VWO.US Exposure
-0.004312496756939141
QQQ.US Exposure
0.09674981408354816
VTV.US Exposure
0.010390086883576127
IJR.US Exposure
-0.004623908443857166
QUAL.US Exposure
0.014684514464608117
SHV.US Exposure
0.5186760673283667
TLT.US Exposure
0.0006444934339838203
LQD.US Exposure
-0.00004562795702182454
HYG.US Exposure
-0.0009972587996705897
GLD.US Exposure
0.0006273572278404758
USO.US Exposure
0.01124601405326259
VNQ.US Exposure
0.03457701748456054
BTC-USD.CC Exposure
0.01870659229517963
CPER.US Exposure
0.022727724599845626
VIX.INDX Exposure
-0.0015640418071478101
UUP.US Exposure
0.010340981121557955
TIP.US Exposure
0.029143128191123996
Idiosyncratic Exposure
0.234056694210201
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
126.3%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$6.8B
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-7.8%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+32.1%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
16.9% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
-1.22
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Belite Bio Inc ADR a high-risk investment?

Belite Bio Inc ADR (BLTE.US) has an annualized volatility of 126.3% and experienced a maximum drawdown of 67.8% over the last 10 years. Its primary macro risk driver is SHV.US.

What is the 10-year return of BLTE.US?

Over the past 10 years, BLTE.US has generated a Compound Annual Growth Rate (CAGR) of 57.2%. It has had a positive return in 75% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Belite Bio Inc ADR

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest